Table 5. Multiple linear regression of the associations between metabolic syndrome components and intraocular pressure using.
| Variables | Coefficient B | SE | t | P value |
|---|---|---|---|---|
| Male | −0.14 | 0.12 | −1.12 | 0.264 |
| High blood pressure | 0.22 | 0.18 | 1.18 | 0.238 |
| High fasting glucose | 0.29 | 0.14 | 2.10 | 0.037* |
| High fasting insulin | 0.25 | 0.22 | 1.14 | 0.257 |
| High HOMA-IR | 0.15 | 0.19 | 0.80 | 0.423 |
| High BMI | 0.01 | 0.18 | 0.04 | 0.965 |
| Abdominal obesity | 0.12 | 0.20 | 0.60 | 0.546 |
| High triglycerides | 0.39 | 0.18 | 2.23 | 0.027* |
| Low HDL-C | −0.32 | 0.17 | −1.87 | 0.064 |
Metabolic syndrome components; high blood pressure (systolic ≥ 130 mmHg or diastolic ≥ 85 mmHg); high fasting glucose (≥ 100 mg/dL); high fasting insulin (≥ 13 μIU/mL); high HOMA-IR (≥ 2.34); high BMI (≥ 25 kg/m2); abdominal obesity (male ≥ 90 cm, female ≥ 85 cm); high triglycerides (≥ 150 mg/dL); low HDL-C (male < 40 mg/dL, female < 50 mg/dL).
SE = standard error, HOMA-IR = homeostasis model assessment of insulin resistance, BMI = body mass index, HDL-C = high-density lipoprotein cholesterol.
*P < 0.05 was considered statistically significant.